A Phase I/IIa, First Time in Human, Study of GSK2636771 in Subjects With Advanced Solid Tumors With Phosphatase and Tensin Homolog (PTEN) Deficiency
Clinical trial NCT01458067 · COMPLETED
Trial details
- NCT number
- NCT01458067
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-10
- Primary completion
- 2015-11-12
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.